Sio Capital Management, LLC

NEW YORK, NY · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 16, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$469.8M2026 Q3+ $58.8M options (notional, not included)
Positions55
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.47.3%

Sio Capital Management, LLC reported 55 positions worth $469.8M as of September 30, 2026 (13F filed November 16, 2026). Largest holding: AVR (7.6%). Biggest move: exit COR ($49.1M).

10 / 55 positions shown
#SymbolCompanyValue ↓% Port.Shares1YYTDSince reported
▸ 1 AVRAnteris Technologies Global$40.2M7.61%5,179,464——-30.2%
▸ 2 GMEDGlobus Medical$35.7M6.75%476,109——-5.9%
▸ 3 GSKGSK$32.3M6.12%671,121——+4.7%
▸ 4 ICLRIcon$24.0M4.53%140,999——+12.6%
▸ 5 SENSSenseonics$23.3M4.41%2,290,860——+4.0%
▸ 6 MRKPutMerck$21.8M notional4.12%150,000———
▸ 7 MRKMerck$21.1M4.00%145,485——-0.6%
▸ 8 IDYAIDEAYA Biosciences$19.2M3.64%500,117——-17.2%
▸ 9 PFEPutPfizer$17.1M notional3.24%600,000———
▸ 10 SLSPutSELLAS Life Sciences$15.1M notional2.87%1,230,700———

Pro Feature

The remaining 45 positions with Pro.

Upgrade to Pro

Read the 2026-Q2 quarterly report · 13F Filing Calendar

🔔 Tell me when this fund files a new 13F

No account needed: in your inbox the morning it is published.

Frequently Asked Questions

What stocks does Sio Capital Management, LLC hold as of Q3 2026?

Sio Capital Management, LLC reported 55 positions worth $469.8M in its Q3 2026 13F filing. Largest positions: AVR (7.6%), GMED (6.7%), GSK (6.1%), ICLR (4.5%) and SENS (4.4%).

What did Sio Capital Management, LLC buy in Q3 2026?

New positions: MRK, MRK, PFE, REPL and BMRN (15 in all). Added to: GMED, GSK, RLMD, ICLR and AVAH (20 in all).

What did Sio Capital Management, LLC sell in Q3 2026?

Reduced: MMS, HELP, ALLO, CI and VTRS (12 in all). Sold out entirely: COR, TYRA, WAY, ORKA and CCRN (19 in all).

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.